These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38583804)
1. Managing patients with intellectual disability and epilepsy in the acute medical setting. Samarasekera S Clin Med (Lond); 2024 Mar; 24(2):100039. PubMed ID: 38583804 [No Abstract] [Full Text] [Related]
2. Clinical guidelines for the management of epilepsy in adults with an intellectual disability. Working group of the International Association of the Scientific Study of Intellectual Disability Seizure; 2001 Sep; 10(6):401-9. PubMed ID: 11700992 [TBL] [Abstract][Full Text] [Related]
3. Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidance. Watkins L; O'Dwyer M; Kerr M; Scheepers M; Courtenay K; Shankar R Expert Opin Pharmacother; 2020 Feb; 21(2):173-181. PubMed ID: 31790280 [No Abstract] [Full Text] [Related]
4. Topiramate: uses in people with an intellectual disability who have epilepsy. Kerr MP J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():74-9. PubMed ID: 10030437 [TBL] [Abstract][Full Text] [Related]
5. Post-electroconvulsive therapy status epilepticus and tardive seizure in a patient with rapid cycling bipolar disorder, epilepsy, and intellectual disability. Chathanchirayil SJ; Bhat R J ECT; 2012 Sep; 28(3):183-4. PubMed ID: 22868490 [TBL] [Abstract][Full Text] [Related]
6. In response: Evaluating the care of a multidisciplinary clinic by using the White Paper "Listening for a change: Medical and social needs of people with intellectual disability who have epilepsy". Kerr M; Linehan C; Thompson R; Mula M; Gil-Nagal A; Zuberi SM; Glynn M Epilepsia; 2015 Sep; 56(9):1473-4. PubMed ID: 26340702 [No Abstract] [Full Text] [Related]
7. Letter: Evaluating the care of a multidisciplinary clinic by using the White Paper "Listening for a change: Medical and social needs of people with intellectual disability who have epilepsy". van der Linden PF; Tan IY; van Erp MG; van Blarikom W; Schelhaas HJ; Majoie MH Epilepsia; 2015 Sep; 56(9):1472-3. PubMed ID: 26340701 [No Abstract] [Full Text] [Related]
8. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. Gaily E; Granström ML; Liukkonen E J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431 [TBL] [Abstract][Full Text] [Related]
9. A White Paper on the medical and social needs of people with epilepsy and intellectual disability: the Task Force on Intellectual Disabilities and Epilepsy of the International League Against Epilepsy. Kerr M; Linehan C; Thompson R; Mula M; Gil-Nagal A; Zuberi SM; Glynn M Epilepsia; 2014 Dec; 55(12):1902-6. PubMed ID: 25378101 [TBL] [Abstract][Full Text] [Related]
10. Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study. Doherty CP; Rheims S; Assenza G; Boero G; Chaves J; McMurray R; Villanueva V J Neurol Sci; 2019 Jul; 402():88-99. PubMed ID: 31128460 [TBL] [Abstract][Full Text] [Related]
12. Effects of music on seizure frequency in institutionalized subjects with severe/profound intellectual disability and drug-resistant epilepsy. D'Alessandro P; Giuglietti M; Baglioni A; Verdolini N; Murgia N; Piccirilli M; Elisei S Psychiatr Danub; 2017 Sep; 29(Suppl 3):399-404. PubMed ID: 28953798 [TBL] [Abstract][Full Text] [Related]
13. The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions. Brenner J; Majoie HJM; van Beek S; Carpay JA Seizure; 2017 Nov; 52():123-130. PubMed ID: 29031193 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine in the treatment of epilepsy in people with intellectual disability. Besag FM J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():50-6. PubMed ID: 10030433 [TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drugs, occurrence of seizures and effect of co-administration of potential seizure threshold-lowering psychotropic drugs in adults with intellectual disability who have epilepsy. Monaghan R; O'Dwyer M; Luus R; Mulryan N; McCallion P; McCarron M; Henman MC J Appl Res Intellect Disabil; 2021 May; 34(3):818-829. PubMed ID: 33530136 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of brivaracetam in patients with intellectual disability and epilepsy. Gillis RME; Wammes-van der Heijden EA; Schelhaas HJ; Tan IY; Festen DAM; Majoie MHJM Acta Neurol Belg; 2021 Jun; 121(3):677-684. PubMed ID: 32157673 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Kerr MP; Baker GA; Brodie MJ Epilepsy Behav; 2005 Nov; 7(3):472-80. PubMed ID: 16140593 [TBL] [Abstract][Full Text] [Related]
18. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. Daugaard CA; Pedersen L; Sun Y; Dreier JW; Christensen J JAMA Netw Open; 2020 Nov; 3(11):e2025570. PubMed ID: 33170264 [TBL] [Abstract][Full Text] [Related]
19. Effects of nydrane on epilepsy in mental defectives. SHARPE DS; DUTTON G; MIRREY JR Br Med J; 1958 May; 1(5078):1044-6. PubMed ID: 13536415 [No Abstract] [Full Text] [Related]